|
Aug 27
|
PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection
|
|
May 15
|
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
|
|
Dec 22
|
PaxMedica Files 8-K Following Nasdaq Compliance Achievement
|
|
Dec 19
|
PaxMedica CEO Howard Weisman Sheds Light on Achievements for ASD Therapy Pipeline
|
|
Dec 6
|
PaxMedica Releases Fireside Chat Video with CEO Howard Weisman
|
|
Dec 1
|
PaxMedica Closes on Public Offering Reaching Estimated $7M
|
|
Aug 9
|
PaxMedica, Inc. Announces Second Quarter 2023 Financial Results and Business Update
|
|
Aug 8
|
PaxMedica to Join Fireside Chat with PCG Advisory Following Positive Top Line Results from PAX-HAT-301 Study
|